Live Yum Brands Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BIOFORCE NANOSCIENCES HOLDINGS, INC.

Get SEC filing alerts via email and in your feed for BIOFORCE NANOSCIENCES HOLDINGS, INC.

BFNH

BIOFORCE NANOSCIENCES HOLDINGS, INC.

About BIOFORCE NANOSCIENCES HOLDINGS, INC.

BioForce Nanosciences Holdings, Inc. operates in the nutritional supplements industry, focusing on natural vitamins, minerals, powders, and beverages designed to support healthier lifestyles for active individuals across all ages. Its core product, BioForce Eclipse, is a private-label multivitamin and mineral powder marketed through distributors, retailers, and online channels. The company leverages contract manufacturing and private labeling to deliver quality supplements targeting athletes, health-conscious consumers, and the elderly in the U.S. market.
This description was generated via AI from an annual report. Updated 10 months ago.

Latest SEC Filings from BIOFORCE NANOSCIENCES HOLDINGS, INC.

1
1
BIOFORCE NANOSCIENCES HOLDINGS, INC. BioForce Nanosciences Reports Improved Net Loss of $102,411 in Q1 2026

Via official filing (AI summary) | 2 months ago | 0 comments

2
1
BIOFORCE NANOSCIENCES HOLDINGS, INC. BioForce Nanosciences Reports No Revenue and Increased Losses for 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
BIOFORCE NANOSCIENCES HOLDINGS, INC. BioForce Nanosciences Reports No Revenue and Increased Losses in Q3 2025

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
BIOFORCE NANOSCIENCES HOLDINGS, INC. BioForce Nanosciences Reports No Revenue and Increased Losses in Q2 2025

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
BIOFORCE NANOSCIENCES HOLDINGS, INC. BioForce Nanosciences Reports Q1 2025 Financial Results with Increased Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
BIOFORCE NANOSCIENCES HOLDINGS, INC. BioForce Nanosciences Reports No Revenue and Increased Losses for Fiscal Years 2023 and 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
BIOFORCE NANOSCIENCES HOLDINGS, INC. Bioforce Nanosciences Holdings Reports Significant Financial Challenges, Net Losses, and Working Capital Deficit

Via official filing (AI summary) | over 1 year ago | 0 comments